Glucagon receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  • Dominique Bataille INSERM
  • Susan L. Chan University of Nottingham
  • Philippe Delagrange Servier
  • Daniel J. Drucker University of Toronto
  • Burkhard Göke University of Hamburg
  • Rebecca Hills University of Edinburgh
  • Kelly E. Mayo Northwestern University
  • Laurence J. Miller Mayo Clinic
  • Roberto Salvatori Johns Hopkins Hospital
  • Bernard Thorens University of Lausanne


The glucagon family of receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on the Glucagon receptor family [159]) are activated by the endogenous peptide (27-44 aa) hormones glucagon, glucagon-like peptide 1, glucagon-like peptide 2, glucose-dependent insulinotropic polypeptide (also known as gastric inhibitory polypeptide), GHRH and secretin. One common precursor (GCG) generates glucagon, glucagon-like peptide 1 and glucagon-like peptide 2 peptides [116]. For a recent review on review the current understanding of the structures of GLP-1 and GLP-1R, the molecular basis of their interaction, and the signaling events associated with it, see de Graaf et al., 2016 [87].
How to Cite
Bataille, D., Chan, S. L., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R. and Thorens, B. (2019) “Glucagon receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database”, IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). doi: 10.2218/gtopdb/F29/2019.4.